Noxopharm Limited (Noxopharm)

Oncology Corporate Profile

Stock Performance


HQ Location

PO Box 824, Turramurra
2074 NSW, Australia

Company Description

Noxopharm is an Australian drug development company with offices in Sydney, Melbourne and Hong Kong. The Company has a primary focus on the development of drugs to address the problem of drug-resistance in cancer cells, the major hurdle facing improved survival prospects for cancer patients. NOX66 is the first pipeline product, with later generation drug candidates under development. The Company also has initiated a pipeline of non-oncology drugs.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NOX66kinase inhibitorProstate cancerI

View additional information on product candidates here »


Recent News Headlines

There are no news items to display